Day: September 13, 2022

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Canada

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Canada

LA JOLLA, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Canadian Intellectual Property Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia. Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than July 2034. The allowed claims cover the use of MN-001 or MN-002 for reducing a triglyceride blood level, for reducing a total cholesterol blood level, and for reducing a low density lipoprotein (LDL) blood level....

Continue reading

Pinehurst Capital II Inc. Announces Filing of Filing Statement with Respect to its Qualifying Transaction with Halcones Precious Metals Inc.

Pinehurst Capital II Inc. Announces Filing of Filing Statement with Respect to its Qualifying Transaction with Halcones Precious Metals Inc.

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRES TORONTO, ON, Sept. 13, 2022 (GLOBE NEWSWIRE) — Pinehurst Capital II Inc. (TSXV: PINH.P) (the “Company”), a Capital Pool Company, as defined in the policies of the TSX Venture Exchange (the “TSXV”), is pleased to announce that, in connection with its previously announced “Qualifying Transaction” (the “Transaction”) pursuant to TSXV Policy 2.4 – Capital Pool Companies (the “CPC Policy”) with Halcones Precious Metals Inc. (“Halcones”), the Company today filed a filing statement in connection with the Transaction (the “Filing Statement”) on the Company’s profile on SEDAR at www.sedar.com. Following the completion of the Transaction, the Company (the “Resulting Issuer”) will carry on the business of Halcones and intends to change its name to “Halcones Precious Metals...

Continue reading

MINILUXE SHAREHOLDERS RECOMMIT TO VOLUNTARY LOCK-UP

MINILUXE SHAREHOLDERS RECOMMIT TO VOLUNTARY LOCK-UP

Toronto, Ontario, Sept. 13, 2022 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp (TSXV: MNLX) announced today that its core shareholders representing approximately 75% of the issued and outstanding shares of the Company have recommitted to a voluntary lock-up agreement for the next twelve months. Executive Chairman Anthony Tjan commented, “Core shareholders are committed to the long-term growth and value creation in MiniLuxe as it moves towards a vision of being the leading lifestyle brand and talent empowerment platform for the nail and waxing industry. The lock-up is reflective of shareholders who are aligned with our mission and excited by the company’s intrinsic value and growth trajectory.” About MiniLuxe MiniLuxe, a Delaware corporation based in Boston, Massachusetts is a digital-first, socially-responsible lifestyle brand and talent...

Continue reading

Soluna Holdings, Inc. Extends Maturity Date of October Notes to April 2023

Soluna Holdings, Inc. Extends Maturity Date of October Notes to April 2023

ALBANY, NY, Sept. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Soluna Holdings, Inc. (“SHI” or the “Company”), (NASDAQ: SLNH), the parent company of Soluna Computing, Inc. (“SCI”), a developer of green data centers for cryptocurrency mining and other intensive computing, today announced that it has entered into a further amendment to its convertible notes (the “Notes”) which were issued on October 25, 2021.  The Company has agreed with the noteholders to amend the terms of the Notes and to extend the Notes’ maturity date until April 25, 2023. The amendment also allows for the Company to have released to it the $1,000,000 currently on deposit, though by October 17, 2022, the Company is required to re-escrow this amount. The Company will also not be required to make the next $950,000 escrow deposit that would have been due on September...

Continue reading

Goosehead Insurance, Inc. Reiterates Full Year 2022 Outlook

Goosehead Insurance, Inc. Reiterates Full Year 2022 Outlook

WESTLAKE, Texas, Sept. 13, 2022 (GLOBE NEWSWIRE) — Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD), a rapidly growing independent personal lines insurance agency, announced today that the company reiterates its full year 2022 outlook. The Company’s outlook for full year 2022 is as follows: Total written premiums placed for 2022 are expected to be between $2.152 billion and $2.215 billion, representing organic growth of 38% on the low end of the range to 42% on the high end of the range. Total revenues for 2022 are expected to be between $194 million and $205 million, representing organic growth of 28% on the low end of the range to 35% on the high end of the range, driven by high levels of Core Revenue growth partly offset by lower than historical average contingent commissions of $8-10 million for the...

Continue reading

NGM Bio Presents Updated Preliminary Findings from the Ongoing Phase 1b Dose Escalation Trial of NGM120 in Combination with Gemcitabine and Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer at AACR Special Conference: Pancreatic Cancer

NGM Bio Presents Updated Preliminary Findings from the Ongoing Phase 1b Dose Escalation Trial of NGM120 in Combination with Gemcitabine and Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer at AACR Special Conference: Pancreatic Cancer

NGM120 is a novel antagonist antibody that binds GFRAL and inhibits GDF15 signaling for the potential treatment of cancer NGM120 has been well tolerated to date in patients in the Phase 1b combination cohort (NGM120 + gemcitabine + Nab-paclitaxel) with no dose-limiting toxicities As of the March 15, 2022 abstract data cut-off date, among the six evaluable patients in the Phase 1b combination cohort, a disease control rate of 100% was observed, median progression-free survival had not been reached and the 12-month survival rate was 83.3% Three of the six evaluable patients experienced partial responses (PR) extending more than 32 weeks as of the abstract cut-off date, including one patient with a PR that was ongoing at 90 weeks as of August 15, 2022 SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals,...

Continue reading

Stellantis and General Motors to Execute a Share Repurchase Transaction

Stellantis and General Motors to Execute a Share Repurchase Transaction

Stellantis and General Motors to Execute a Share Repurchase Transaction AMSTERDAM, Sept. 13, 2022 – Stellantis N.V. and General Motors Holdings LLC, a subsidiary of General Motors Company (“GM”) have executed a share repurchase agreement (“SRA”) related to the 69.1 million common shares in Stellantis, representing approximately 2.2% of Stellantis’ share capital (on a diluted basis), that GM is entitled to receive upon the exercise of equity warrants (the “Warrants”) originally issued by Peugeot S.A. (“PSA”) to GM in 2017. The Warrants were issued to GM as part of the purchase by PSA of the Opel Vauxhall automotive business. Upon exercise of the Warrants, Stellantis will also deliver to GM approximately 1.2 million common shares of Faurecia and an aggregate cash amount of approximately EUR130 million for rights to dividends paid by PSA...

Continue reading

<div>17 Education & Technology Group Inc. Announces Second Quarter 2022 Unaudited Financial Results</div>

17 Education & Technology Group Inc. Announces Second Quarter 2022 Unaudited Financial Results

BEIJING, China, Sept. 13, 2022 (GLOBE NEWSWIRE) — 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading education technology company in China, today announced its unaudited financial results for the second quarter of 2022. Second Quarter 2022 Highlights1 Net revenues were RMB133.5 million (US$19.9 million), representing a year-over-year decrease of 80.1% from RMB670.9 million in the second quarter of 2021, and 11.2% higher than the high end of the estimate provided by the Company in June 2022. Gross margin was 52.2%, compared with 63.0% in the second quarter of 2021. Net loss was RMB26.4 million (US$3.9 million), significantly decreasing from net loss of RMB266.7 million in the second quarter of 2021. Net loss as a percentage of net revenues was negative 19.8% in the second quarter of...

Continue reading

Currency Exchange International Announces Record Financial Results for the Three and Nine-Month Periods Ended July 31, 2022

Currency Exchange International Announces Record Financial Results for the Three and Nine-Month Periods Ended July 31, 2022

TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) — Currency Exchange International, Corp. (the “Company”) (TSX: CXI; OTCBB: CURN), announces its financial results and management’s discussion and analysis (“MD&A”) for the three and nine-month periods ended July 31, 2022 (all figures are in U.S. dollars except where otherwise indicated). The complete financial statements and MD&A can be found on the Company’s SEDAR profile at www.sedar.com. Randolph Pinna, CEO of the Company, stated, “Q3 was another record quarter for CXI that exceeded our expectations. The Group generated revenue that was 67% higher than our pre-pandemic peak in Q3 2019. More than a third of that increase came from our Payments business, a segment that was relatively nascent in 2019. Our global banknote expansion with foreign financial institution clients...

Continue reading

Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms Third Quarter 2022 Earnings Release and Conference Call

Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms Third Quarter 2022 Earnings Release and Conference Call

PHILADELPHIA, Sept. 13, 2022 (GLOBE NEWSWIRE) — Brandywine Realty Trust (NYSE:BDN) announced today that its Board of Trustees has declared a quarterly cash dividend of $0.19 per common share and OP Unit payable on October 20, 2022 to holders of record on October 6, 2022. The quarterly dividend is equivalent to an annual rate of $0.76 per share. Conference Call and Audio Webcast We will release our third quarter earnings after the market close on Thursday, October 20, 2022, and will hold our third quarter conference call on Friday, October 21, 2022 at 9:00 a.m. Eastern. To access the conference call by phone, please visit this link here, and you will be provided with dial in details. A live webcast of the conference call will also be available on the Investor Relations page of our website at www.brandywinerealty.com. About Brandywine...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.